BSX vs GUTS · P/E 20, rev $10.65B vs $74.9M cap
Boston Scientific Corp (BSX) versus Fractyl Health, Inc. Common Stock (GUTS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Fractyl Health, Inc. Common Stock (GUTS) is a biotechnology company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported GUTS revenue for 2025-12-31 was $0. Net income was -$141.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. GUTS currently screens at market cap $74.9M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. GUTS currently screens at market cap $74.9M.
Not investment advice. Open the BSX and GUTS stock pages for the full models.
Not investment advice.